Clinical trials
Observational Churg-Strauss Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2022 | 1 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 9 |
| Unknown status | 5 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Pennsylvania | 6 |
| University of South Florida | 4 |
| GlaxoSmithKline | 3 |
| Charite University, Berlin, Germany | 2 |
| European EGPA Study Group | 2 |
| University of Oxford | 2 |
| AstraZeneca | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Medical University Innsbruck | 1 |
| Meyer Children's Hospital IRCCS | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Churg-Strauss Syndrome | 30 |
| Microscopic Polyangiitis | 16 |
| Granulomatosis with Polyangiitis | 15 |
| Polyarteritis Nodosa | 11 |
| Takayasu Arteritis | 10 |
| Vasculitis | 10 |
| Giant Cell Arteritis | 8 |
| IgA Vasculitis | 7 |
| Behcet Syndrome | 6 |
| Vasculitis, Central Nervous System | 6 |
Trials
Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.